Revenue from operations jumped 21% to Rs 4,302 crore in the March quarter. The company had reported revenues of Rs 3,546 crore in the last year period.
The Board has also recommended a final dividend of Rs 9 per equity share (180%) of the face value of Rs 5 per share to the shareholders of the company for FY23.
The dividend recommended by the Board is subject to the approval of the shareholders at the annual general meeting. The company has fixed August 19 as the record date to determine the eligibility of shareholders for the said dividend payment.
The dividend, if approved by the shareholders at the AGM, will be paid on and from September 9.
During the quarter, the company's EBITDA (earnings before interest, tax, depreciation and amortisation) stood at Rs 488 crore, up 5% from Rs 463 crore in Q4FY22.
Segment-wise, healthcare services revenues increased 18% to Rs 2,227 crore in the reporting quarter. It was Rs 1,879 crore in the previous year's quarter.
Retail health and diagnostics clocked revenues of Rs 308 crore for the January-March period, up by a marginal 4% compared to Rs 297 crore a year ago.
Digital health and primary distribution, on the other hand, saw revenue growth of 31% YoY to Rs 1,799 crore during the March quarter.
For the full year, Apollo Hospitals recorded a profit of Rs 844 crore, which is down nearly 24%. The profit stood at Rs 1,108 crore in the previous fiscal year.
Revenues in FY23 grew 13% to Rs 16,612 crore as against Rs 14,662 crore in FY22.
On Tuesday, Apollo Hospitals shares were down 0.87% to settle at Rs 4,600 on NSE.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price